The U.S. Food and Drug Administration (FDA) has delayed granting full approval of Novavax’s COVID-19 jab.
According to POLITICO, a top FDA official “directly intervened” in an agency review.
Inching very slowly towards the finish line. pic.twitter.com/HT4g202FPX
— Mary Talley Bowden MD (@MdBreathe) April 3, 2025
Trending: Why Do 10 Nurses at the Same Hospital Have Brain Tumors?
From POLITICO:
Dr. Sara Brenner, FDA’s Principal Deputy Commissioner, took the highly unusual step, cutting against longstanding precedent at the agency designed to shield scientific assessments from political interference. Typically, political FDA appointees follow the advice of career staff tasked with reviewing reams of data on drugs and vaccines seeking approval.
The move comes amid HHS Secretary Robert F. Kennedy Jr.’s decision to force out the top official responsible for reviewing such vaccines, Dr. Peter Marks, and put
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!